Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Additional targets introduce additional interactions, and a stronger average trial result can come with more adverse events, uncertain long-term effects, or a different response across patient groups
Your digestion changes
May worsen with high fat foods or inconsistent eating patterns
Drink plenty of water throughout the day to stay hydrated
Supportive adjustments can make a meaningful difference
Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial
US$ 29.21
US$ 22.03
US$ 27.02
